CSPG4 and acute lymphoblastic leukemia: Therefore, the consensus is that de novo expression of NG2/CSPG4 tightly correlates with 11q23-linked genetic abnormalities and identifies a specific and well-defined subset of leukemic patients with dismal prognosis, as also exemplified by the outcome of the GMALL study on CD10− adult pre-B ALL [4].